Skip to content
Back to MET

MetLife Inc

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
2
Purchases
0
Sales
2
Purchase value
$0.00
Sale value
$21.04M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Michel KhalafDirector · President & CEO
4
Filed Nov 12, 2026Period of report Nov 10, 20260001535491-26-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 10, 2026
Common StockF1F2187,425$102.9676$19.30M759,013Direct
Filing footnotes · 7
  1. F1The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on November 10, 2026, and related tax obligations and fees.
  2. F2The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $102.59 to $103.235, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
  3. F3Includes 3,073 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options.
  4. F4The options became exercisable in three equal installments on February 28, 2018, 2019, and 2020.
  5. F5The options became exercisable in three installments on March 2, 2019, 2020 and 2021.
  6. F6The options became exercisable in three installments on February 26, 2020, 2021 and 2022.
  7. F7The options become exercisable in equal installments on each of the first three anniversaries of the grant date.
Open on SEC EDGAR
Marlene DebelEVP & Chief Risk Officer
4
Filed Jun 3, 2026Period of report Jun 1, 20260001770295-26-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 1, 2026
Common StockF121,312$81.5889$1.74M154,380Direct
Filing footnotes · 3
  1. F1The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $81.57 to $81.65, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
  2. F2The options became exercisable in three substantially equal installments on February 28, 2018, 2019, and 2020.
  3. F3The options became exercisable in three substantially equal installments on March 2, 2019, 2020, and 2021.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.